Amicus Therapeutics, Inc. (0HF9.L)

USD 6.78

(-3.9%)

Inventory Summary of Amicus Therapeutics, Inc.

  • Amicus Therapeutics, Inc.'s latest annual inventory in 2023 was 59.69 Million USD , up 150.66% from previous year.
  • Amicus Therapeutics, Inc.'s latest quarterly inventory in 2024 Q1 was 60.75 Million USD , up 1.78% from previous quarter.
  • Amicus Therapeutics, Inc. reported annual inventory of 23.81 Million USD in 2022, down -11.19% from previous year.
  • Amicus Therapeutics, Inc. reported annual inventory of 26.81 Million USD in 2021, up 37.13% from previous year.
  • Amicus Therapeutics, Inc. reported quarterly inventory of 60.75 Million USD for 2024 Q1, up 1.78% from previous quarter.
  • Amicus Therapeutics, Inc. reported quarterly inventory of 27 Million USD for 2023 Q1, up 13.39% from previous quarter.

Annual Inventory Chart of Amicus Therapeutics, Inc. (2023 - 2003)

Created with Highcharts 11.1.0YearsInventory20042006200820102012201420162018202020220 USD20000000 USD40000000 USD60000000 USD80000000 USD

Historical Annual Inventory of Amicus Therapeutics, Inc. (2023 - 2003)

Year Inventory Inventory Growth
2023 59.69 Million USD 150.66%
2022 23.81 Million USD -11.19%
2021 26.81 Million USD 37.13%
2020 19.55 Million USD 39.28%
2019 14.04 Million USD 67.35%
2018 8.39 Million USD 81.48%
2017 4.62 Million USD 35.33%
2016 3.41 Million USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%
2005 - USD 0.0%
2003 - USD 0.0%

Peer Inventory Comparison of Amicus Therapeutics, Inc.

Name Inventory Inventory Difference
uniQure N.V. 12.02 Million USD -396.474%
Agios Pharmaceuticals, Inc. 19.07 Million USD -212.938%
Atara Biotherapeutics, Inc. 9.7 Million USD -515.042%
bluebird bio, Inc. 22.91 Million USD -160.465%
Cara Therapeutics, Inc. 2.82 Million USD -2016.129%
Imunon, Inc. - USD -Infinity%
Editas Medicine, Inc. - USD -Infinity%
IQVIA Holdings Inc. - USD -Infinity%
Mettler-Toledo International Inc. 385.86 Million USD 84.529%
Myriad Genetics, Inc. 20.1 Million USD -196.995%
Neurocrine Biosciences, Inc. 38.3 Million USD -55.864%
Supernus Pharmaceuticals, Inc. 77.4 Million USD 22.881%
Verastem, Inc. - USD -Infinity%
Walgreens Boots Alliance, Inc. 8.32 Billion USD 99.283%
Waters Corporation 516.23 Million USD 88.436%
Thermo Fisher Scientific Inc. 5.08 Billion USD 98.827%
Biogen Inc. 2.52 Billion USD 97.638%
Nektar Therapeutics 16.1 Million USD -270.76%
Perrigo Company plc 1.14 Billion USD 94.768%
Dynavax Technologies Corporation 53.29 Million USD -12.021%
Illumina, Inc. 587 Million USD 89.83%
Corbus Pharmaceuticals Holdings, Inc. - USD -Infinity%
Iovance Biotherapeutics, Inc. 10.37 Million USD -475.55%
Heron Therapeutics, Inc. 42.11 Million USD -41.762%
Unity Biotechnology, Inc. - USD -Infinity%
BioMarin Pharmaceutical Inc. 1.1 Billion USD 94.608%
Sangamo Therapeutics, Inc. - USD -Infinity%
Evolus, Inc. 10.99 Million USD -442.79%
Adicet Bio, Inc. - USD -Infinity%
Aclaris Therapeutics, Inc. - USD -Infinity%
Regeneron Pharmaceuticals, Inc. 2.58 Billion USD 97.687%
Esperion Therapeutics, Inc. 65.62 Million USD 9.032%
FibroGen, Inc. 41.56 Million USD -43.621%
Agilent Technologies, Inc. 1.03 Billion USD 94.21%
OPKO Health, Inc. 65.69 Million USD 9.134%
Homology Medicines, Inc. - USD -Infinity%
Geron Corporation - USD -Infinity%
Alnylam Pharmaceuticals, Inc. 89.14 Million USD 33.036%
Exelixis, Inc. 17.32 Million USD -244.605%
Viking Therapeutics, Inc. - USD -Infinity%
Anavex Life Sciences Corp. - USD -Infinity%
Intellia Therapeutics, Inc. - USD -Infinity%
Zoetis Inc. 2.56 Billion USD 97.672%
Axsome Therapeutics, Inc. 15.13 Million USD -294.424%
Abeona Therapeutics Inc. -2.44 Million USD 2542.553%
Vertex Pharmaceuticals Incorporated 738.8 Million USD 91.92%
Kala Pharmaceuticals, Inc. - USD -Infinity%
Ionis Pharmaceuticals, Inc. 28.42 Million USD -110.012%
Sarepta Therapeutics, Inc. 322.85 Million USD 81.51%
Corcept Therapeutics Incorporated 7.73 Million USD -672.264%
Halozyme Therapeutics, Inc. 127.6 Million USD 53.217%
Blueprint Medicines Corporation 21.22 Million USD -181.28%
Insmed Incorporated 83.24 Million USD 28.291%
TG Therapeutics, Inc. 39.82 Million USD -49.903%
Incyte Corporation 62.97 Million USD 5.202%
Emergent BioSolutions Inc. 328.9 Million USD 81.85%